Novartis India enters into Supply & Distribution Agreement with Themis Medicare

17 Sep 2013 Evaluate

Novartis India has entered into a Supply & Distribution Agreement with Themis Medicare on August 16, 2013. As per agreement, Themis has agreed to manufacture and supply and Novartis has agreed long term exclusive purchase from Themis Diclofenac Sodium 75 mg per ml Injection as finished dosage pharmaceutical form on certain commercial terms and conditions for Indian market.

Novartis India is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare.

Novartis Share Price

996.50 166.05 (20.00%)
20-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 251.40
Adani Enterprises 2160.45
Amrapali Industries 14.35
Rashi Peripheral 359.60
PDS 306.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×